Michael Powell – Startup Investor Profile

Dr. Michael Powell, as the Managing General Partner at Sofinnova Ventures, focuses on companies in the therapeutics sector, particularly in cancer, neurology, dermatology, and rare diseases. His investment thesis revolves around drug development, leveraging his extensive experience in the biotech industry. Sofinnova Ventures under his leadership seeks life science companies in clinically later-stage assets. Dr. Powell’s geographical preference leans toward oncology-related fields. He has a notable track record in drug development, having worked at Genentech and various other biotech companies before joining Sofinnova in 1997. Although specific details on investment check size and partnership styles are not readily available, his career showcases a deep involvement in drug delivery, product development, and venture capital. Dr. Powell has been a key figure in the success of numerous biotech companies, reflecting a strategic and hands-on approach to investments.

Location: San Diego, CA

Country: United States of America

Investment Regions: EU, NA

Investment Stages: pre-seed, seed

Website:

AI Reasoning: I found a Bicara Therapeutics SEC filing stating Michael Powell served as Chair of the board since August 2024 and held board roles through December 2024 at Galera Therapeutics. The most recent investment-related activity (board appointment/chair at Bicara) occurred August 2024, which is between 6 and 12 months before the reference date, so classify as active. The startup involved: Bicara Therapeutics (board appointment) and Galera Therapeutics (board membership until Dec 2024).

Low Activity – Only known angel investments more than 12 months ago.

Active – Known angel investments between the last 12 and 6 months.

Very Active – Known angel investments in the last 6 months.